-
1
-
-
0031967993
-
The ocular manifestations of rheumatoid disease
-
DOI 10.1097/00004397-199803810-00003
-
S Harper C Foster 1998 The ocular manifestations of rheumatoid disease Int Ophthalmol Clin 38 1 19 10.1097/00004397-199803810-00003 1:STN:280:DyaK1c7ptlKntQ%3D%3D 9532469 (Pubitemid 28168568)
-
(1998)
International Ophthalmology Clinics
, vol.38
, Issue.1
, pp. 1-19
-
-
Harper, S.L.1
Foster, C.S.2
-
2
-
-
0017162416
-
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis
-
10.1136/bjo.60.3.192 1:STN:280:DyaE287osVKlsA%3D%3D
-
D McGavin J Williamson J Forrester W Foulds W Buchanan W Dick, et al. 1976 Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis Br J Ophtalmol 60 192 226 10.1136/bjo.60.3.192 1:STN:280:DyaE287osVKlsA%3D%3D
-
(1976)
Br J Ophtalmol
, vol.60
, pp. 192-226
-
-
McGavin, D.1
Williamson, J.2
Forrester, J.3
Foulds, W.4
Buchanan, W.5
Dick, W.6
-
3
-
-
0033798353
-
Episcleritis and scleritis: Clinical features and treatment results
-
10.1016/S0002-9394(00)00710-8 1:STN:280:DC%2BD3M%2Fhtl2ntg%3D%3D 11024419
-
D Jabs A Mudun J Dunn M Marsh 2000 Episcleritis and scleritis: clinical features and treatment results Am J Ophthalmol 130 469 476 10.1016/S0002- 9394(00)00710-8 1:STN:280:DC%2BD3M%2Fhtl2ntg%3D%3D 11024419
-
(2000)
Am J Ophthalmol
, vol.130
, pp. 469-476
-
-
Jabs, D.1
Mudun, A.2
Dunn, J.3
Marsh, M.4
-
5
-
-
0017079320
-
Scleritis and episcleritis
-
10.1136/bjo.60.3.163 1:STN:280:DyaE287osVKlsw%3D%3D 1268179
-
P Watson S Hayreh 1976 Scleritis and episcleritis Br J Ophthalmol 60 163 191 10.1136/bjo.60.3.163 1:STN:280:DyaE287osVKlsw%3D%3D 1268179
-
(1976)
Br J Ophthalmol
, vol.60
, pp. 163-191
-
-
Watson, P.1
Hayreh, S.2
-
7
-
-
22844433213
-
Necrotizing scleritis associated with rheumatoid arthritis: Long-term remission with high-dose infliximab therapy
-
DOI 10.1093/rheumatology/keh635
-
D Ashok W Ayliffe P Kiely 2005 Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy Rheumatol 44 950 951 10.1093/rheumatology/keh635 1:CAS:528:DC%2BD2MXlslyrsbw%3D (Pubitemid 41511196)
-
(2005)
Rheumatology
, vol.44
, Issue.7
, pp. 950-951
-
-
Ashok, D.1
Ayliffe, W.H.2
Kiely, P.D.W.3
-
8
-
-
66749169278
-
Treatment of refractory scleritis with infliximab
-
10.1007/s10384-008-0652-5
-
S Ahn J Oh M Kim W Wee 2009 Treatment of refractory scleritis with infliximab Jpn J Ophtalmol 53 286 287 10.1007/s10384-008-0652-5
-
(2009)
Jpn J Ophtalmol
, vol.53
, pp. 286-287
-
-
Ahn, S.1
Oh, J.2
Kim, M.3
Wee, W.4
-
9
-
-
67649657499
-
Rituximab for the treatment associated with rheumatoid arthritis
-
10.1136/bjo.2008.147157 1:STN:280:DC%2BD1Mvkt1OnsQ%3D%3D
-
S Chauhan A Kamal R Thompson C Estrach R Moots 2009 Rituximab for the treatment associated with rheumatoid arthritis Br J Ophtalmol 93 984 985 10.1136/bjo.2008.147157 1:STN:280:DC%2BD1Mvkt1OnsQ%3D%3D
-
(2009)
Br J Ophtalmol
, vol.93
, pp. 984-985
-
-
Chauhan, S.1
Kamal, A.2
Thompson, R.3
Estrach, C.4
Moots, R.5
-
10
-
-
2342658406
-
Radiographic, Clinical, and Functional Outcomes of Treatment with Adalimumab (a Human Anti-Tumor Necrosis Factor Monoclonal Antibody) in Patients with Active Rheumatoid Arthritis Receiving Concomitant Methotrexate Therapy: A Randomized, Placebo-Controlled, 52-Week Trial
-
DOI 10.1002/art.20217
-
E Keystone A Kavanaugh J Sharp H Tannenbaum Y Hua L Teoh, et al. 2004 Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial Arthritis Rheum 50 1400 1411 10.1002/art.20217 1:CAS:528:DC%2BD2cXkvFykur4%3D 15146409 (Pubitemid 38608061)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.5
, pp. 1400-1411
-
-
Keystone, E.C.1
Kavanaugh, A.F.2
Sharp, J.T.3
Tannenbaum, H.4
Hua, Y.5
Teoh, L.S.6
Fischkoff, S.A.7
Chartash, E.K.8
|